| ¿µ¹® | anaphylaxis | ÇÑ±Û | ¾Æ³ªÇʶô½Ã½º, °ú¹ÎÁõ |
|---|---|---|---|
| ¼³¸í | ¾Æ³ªÇʶô½Ã½º¶ó´Â ¸»Àº Á¦ 1Çü °ú¹Î¹ÝÀÀ°ú °°Àº ¸»·Î ¿Ü°èÀÇ ¹°Áú¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀÀÌ Áö³ªÄ¡°Ô Ç×ÁøµÇ¾î ÀÖ´Â º´ÀûÀÎ »óŸ¦ ¸»ÇÑ´Ù. ¸é¿ªÀ̶õ ¿ÜºÎ¹°Áú¿¡ ´ëÇÑ ¹æ¾î¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â ¼¼Æ÷µéÀÇ È°µ¿À» ÀǹÌÇϸç, ¿©±â¿¡´Â Ç×üÀÇ Çü¼º, ¼¼Æ÷µéÀÇ Æ÷½ÄÀÛ¿ë(¿ÜºÎ¿¡¼ µé¾î¿Â ¹°ÁúÀ» ¸é¿ª±â´ÉÀ» ÇÏ´Â ¼¼Æ÷°¡ Àâ¾Æ¸Ô´Â °Í)µîÀÌ Æ÷ÇԵȴÙ. Ç×üÀÇ Çü¼ºÀº ¿ÜºÎ·ÎºÎÅÍ µé¾î¿Â ¹°ÁúÀ» ¿ì¼± Å«Æ÷½Ä¼¼Æ÷ µîÀÌ Æ÷½ÄÀ» Çϰí À̰Ϳ¡ ´ëÇÑ Á¤º¸¸¦ T-¸²ÇÁ±¸¿¡°Ô Àü´ÞÇϰí T-¸²ÇÁ±¸´Â ÀÌ Á¤º¸¸¦ ó¸®ÇÏ¿© Áý¾àµÈ Á¤º¸¸¦ B-¸²ÇÁ±¸¿¡°Ô Àü´ÞÇϸç ÀÌ ¼¼Æ÷·Î ÇÏ¿©±Ý ±× ¹°Áú ¿¡ ´ëÇÑ Ç×ü¸¦ »ý¼ºÇÏ°Ô ÇÑ´Ù. Ç×ü´Â ¿ÜºÎÀÇ ¹°Áú°ú Á¤È®È÷ °áÇÕÇÏ¿© ¿ÜºÎÀÇ ¹°ÁúÀÇ È°¼ºÈ¸¦ ¾ø¾Ö´Â ¹°ÁúÀÌ´Ù. ÀÌ·¸°Ô Çü¼ºµÈ Ç×üÁß¿¡¼ IgE¿¡ ºÎÂøµÉ ¼ö ÀÖ´Â, Áï ÀÌ¹Ì Ç×ü IgE°¡ Çü¼ºµÈ(ÀÌ·¸°Ô µÇ±â À§Çؼ´Â ±× ¹°ÁúÀÌ ÀÌÀü¿¡ ÇÑ ¹ø ¸ö¼Ó¿¡ µé¾î ¿Ô¾î¾ß ÇÑ´Ù) ¹°ÁúÀÌ È÷½ºÅ¸¹Î µîÀÇ ¿©·¯ ¹°ÁúÀÌ ³ª¿À°Ô µÇ°í ÀÌ·± ¹°Áúµé¿¡ ÀÇÇØ¼ »ý±â´Â ¿©·¯ °¡Áö ½Åü¿¡ ÇØ·Î¿î ¹ÝÀÀÀÌ »ý°Ü³´Ù. ±×·¡¼ ÇÊ¿ä ÀÌ»óÀ¸·Î °ú¹ÎÇÑ ÀÌ·¯ÇÑ ÇüÅÂÀÇ ¸é¿ªÀÛ¿ëÀ» °ÅÄ¡´Â ¹ÝÀÀÀ» ¾Æ´ÏÇʶô½Ã½º¶ó ÇÑ´Ù. |
||
| ¿µ¹® | immunological reaction | ÇÑ±Û | ¸é¿ª¹ÝÀÀ |
|---|---|---|---|
| ¼³¸í | »ýüÀÇ ¸ö ¾È¿¡¼ »ý±ä ¹°ÁúÀ̳ª ¸ö ¹Û¿¡¼ µé¾î¿Â ¹°ÁúÀÌ »ýü¿Í ´Ù¸¦ ¶§ ÀÚ±â ü³»ÀÇ ÅëÀϼº°ú °³Ã¼ÀÇ »ýÁ¸ À¯Áö ¹× Á¾ÀÇ Á¸¼ÓÀ» À§ÇÏ¿© ±× ¹°ÁúµéÀ» Á¦°ÅÇÏ´Â ÀÏ·ÃÀÇ »ýü ¹ÝÀÀ. ´Ù½Ã ¸»ÇØ B¼¼Æ÷¿¡ ÀÇÇÑ Ç×ü»ý»ê, T¼¼Æ÷¸¦ Áß½ÉÀ¸·Î ÇÏ´Â ¼¼Æ÷¼º ¸é¿ª, ¸é¿ª°ü¿ë, ¸é¿ª±â¾ï µîÀÇ »ýü ³» ¹ÝÀÀÀ» ¸»ÇÑ´Ù. Å«Æ÷½Ä¼¼Æ÷´Â Ç׿øÀ» ó¸®Çؼ ƯÀÌÀûÀÎ Ç׿ø°áÁ¤±â¸¦ °®´Â ºÐÀÚ·Î ¹Ù²ã, Ç׿ø°ú ÁÖ¿äÁ¶Á÷ ÀûÇÕÀ¯ÀüÀÚº¹ÇÕü¸¦ ¼¼Æ÷Ç¥¸é¿¡ Ç¥ÇöÇϸç, T¼¼Æ÷·Î Àü´ÞÇÑ´Ù. ÇÑÆí B¼¼Æ÷´Â Å«Æ÷½Ä¼¼Æ÷ ³»¿¡¼ ó¸®µÈ Ç׿øÀÇ °áÁ¤±â¸¦ ÀνÄÇÏ¿© ´ëÀÀÇϴ ƯÀÌÀûÇ×ü¸¦ »ý»êÇÏ¿© Ç׿øÀ» ó¸®ÇÑ´Ù. |
||
| ¿µ¹® | reaction formation | ÇÑ±Û | ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º |
|---|---|---|---|
| ¼³¸í | ¾ï¾Ðº¸´Ù ´õ Àû±ØÀûÀÎ ¹æ¾î¸ÞÄ¿´ÏÁòÀ̸ç, ¹«ÀǽÄÀûÀÎ »ý°¢, ¼Ò¿ø, Ãæµ¿ÀÌ ³Ê¹«³ªµµ ¹Þ¾Æµé¿©Áú ¼ö ¾ø´Â °ÍÀÏ °æ¿ì¿¡ À̿ʹ Á¤¹Ý´ë ¹æÇâÀÇ °ÍÀ» °Á¶ÇÔÀ¸·Î½á ±×·± ¹«ÀǽÄÀûÀÎ °ÍµéÀÌ ÀǽĵÇÁö ¾Ê°Ô ÇÏ´Â °úÁ¤. ¿¹¸¦ µé¸é °¡Àå °¡ÇÐÀûÀÎ ¼º°ÝÀÇ »ç¶÷ÀÌ »ýÃ¼ÇØºÎ ¹Ý´ë·ÐÀÚ°¡ µÇ´Â °æ¿ì¸¦ µé ¼ö ÀÖ´Ù. À̰ÍÀº ¶Ç °¡½¿ ±íÀÌ Àá°ÜÀÖ´Â µÎ·Á¿òÀÌ ÀǽĵǴ °ÍÀ» ÇÇÇϱâ À§Çؼ µÎ·Á¿òÀÇ ´ë»óÀÌ µÇ´Â Çൿ¿¡ °ñ¸ôÇÏ´Â °æ¿ìµµ Æ÷ÇÔÀÌ µÈ´Ù. ¿¹¸¦ µé¸é, ³²ÀÚ¿¡°Ô »óó¹ÞÁö ¾ÊÀ»±î ÇÏ´Â µÎ·Á¿ò¿¡ °¡µæ Âù ¼Ò³à°¡ ÀÌ °°Àº µÎ·Á¿òÀ» ºÎÁ¤ÇÏ·Á´Â ¼ö´ÜÀ¸·Î ³ÀâÇÑ ¼ºÇàÀ§¿¡ °ñ¸ôÇÏ´Â °æ¿ì°¡ ÀÖ´Ù. ¶Ç ÀüóÀÇ Àڳฦ ¹Ì¿öÇÏ´Â °è¸ð°¡ ¿ÀÈ÷·Á Áö³ªÄ¥ Á¤µµ·Î ±× ¾ÆÀ̸¦ ±Í¿©¿öÇÏ´Â ÀÏ µûÀ§ÀÌ´Ù. |
||
| ¿µ¹® | complement fixation reaction | ÇÑ±Û | º¸Ã¼°áÇÕ ¹ÝÀÀ, µµ¿òü°áÇÕ¹ÝÀÀ |
|---|---|---|---|
| ¼³¸í | Ç×ü¿ÍÀÇ ¹ÝÀÀ¿¡ ÀÖ¾î¼ º¸Ã¼¿Í °áÇÕÇÏ´Â Ç×ü¸¦ °Ë»çÇÏ´Â ¹æ¹ýÀ¸·Î, ÀÌ ¹ÝÀÀÀº ÃÖÃÊ¿¡ ±âÁöÇ׿ø, ÇǰËÇ÷û ¹× º¸Ã¼¸¦ È¥ÇÕÇÑ´Ù. Á¦2´Ü°è¿¡¼´Â ÀûÇ÷±¸¿Í À̰Ϳ¡ ´ëÀÀÇÏ´Â ¿ëÇ÷¼ÒÀÇ È¥ÇÕ¾×À» °¡ÇÑ´Ù. º» ¹ÝÀÀÈÄ ¿ëÇ÷ÀÌ ÀϾÁö ¾ÊÀ¸¸é º»Ã¼´Â Ç׿øÇ×ü°áÇÕ¹°¿¡ °áÇÕÇÑ °ÍÀÌ µÇ¾î ¾ç¼ºÀÌ µÇÁö¸¸, ¿ëÇ÷ÀÌ ÀÏ¾î³ °æ¿ì º¸Ã¼´Â °áÇÕÇÏÁö ¾Ê¾Æ ¼ÒºñµÇÁö ¾Ê±â ¶§¹®¿¡ À½¼ºÀÌ µÈ´Ù. º» ¹ÝÀÀÀº ±âÁöÇ÷ûÀ» ½á¼ Ç׿ø°ËÃâ¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖÀ¸¸ç, ¸¶ÀÌÄÚÇö󽺸¶, ¸®ÄÉÃ, Ŭ¶ó¹Ìµð¾Æ, ¹ÙÀÌ·¯½º, ¸Åµ¶ µîÀÇ Áø´Ü¿¡ ¾²ÀδÙ. |
||
| ¿µ¹® | transfusion reaction | ÇÑ±Û | ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ |
|---|---|---|---|
| ¼³¸í | ¼öÇ÷ÇÏ¿´À» ¶§¿¡ ȯÀÚ¿¡°Ô ÀϾ´Â ¹ÝÀÀ. ¾Ë·¹¸£±â ¹ÝÀÀ°ú ¿ëÇ÷ ¹ÝÀÀÀÌ ÀÖ´Ù. |
||
| PCA | para-chloramphetamine; parietal cell antibody; passive cutaneous anaphylaxis; patient care assistant... |
|---|---|
| RPA | radial photon apsorptiometry; replication protein A; resultant physiologic acceleration; reverse pas... |
| PCA | 1) Passive Cutaneous Araphylaxis 2) Posterior Cerebral Artery |
| LR | labeled release; laboratory references; laboratory report; labor room; lactated Ringer [solution]; l... |
| PAP | pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa... |
| PCA | Passive Cutaneous Anaphylaxis |
|---|---|
| ACA | Active cutaneous anaphylaxis |
| RCA | reverse cutaneous anaphylaxis |
| PCA | Passive cutaneous anaphylactic |
| PAR | passive avoidance reaction |
| passive cutaneous anaphylaxis | An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. Pca is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. (12 Dec 1998) |
|---|---|
| passive cutaneous anaphylaxis test | An animal is injected intradermally with antibody (usually IgE) and subsequently challenged intravenously with a mixture of antigen and Evans blue dye 24-48 hours later. A dark blue area indicates a positive reaction due to the leakage of the dye at the site of antigen-antibody reactions. (05 Mar 2000) |
| passive anaphylaxis | A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations. Synonym: antiserum anaphylaxis. (05 Mar 2000) |
| reversed passive anaphylaxis | An anaphylactic reaction induced in an animal injected with a specific antigen, which will bind to reactive tissue, and then, after a latent period, with serum from another animal previously sensitised to the identical antigen. Synonym: reversed anaphylaxis. (05 Mar 2000) |
| cutaneous graft versus host reaction | An acute erythematous maculopapular reaction with bulla formation in the most severe cases; chronic changes may resemble lichen planus or scleroderma. (05 Mar 2000) |
| cutaneous reaction | The inflammatory reaction in the case of a skin test in a sensitive (allergic) subject. Synonym: cutaneous reaction. Origin: L. Cutis, skin, + reaction (05 Mar 2000) |
| active anaphylaxis | Reaction following inoculation of antigen in a subject previously sensitised to the specific antigen, in contrast to passive anaphylaxis. (05 Mar 2000) |
| aggregate anaphylaxis | <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism. <immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses. Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension. See: hypersensitivity. (18 Nov 1997) |
| anaphylaxis | <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism. <immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses. Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension. See: hypersensitivity. (18 Nov 1997) |
| antiserum anaphylaxis | A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations. Synonym: antiserum anaphylaxis. (05 Mar 2000) |
| generalised anaphylaxis | The immediate response, involving smooth muscles and capillaries throughout the body of a sensitised individual, that follows intravenous (and occasionally intracutaneous) injection of antigen (allergen). See: anaphylactic shock. Synonym: systemic anaphylaxis. (05 Mar 2000) |
| reversed anaphylaxis | An anaphylactic reaction induced in an animal injected with a specific antigen, which will bind to reactive tissue, and then, after a latent period, with serum from another animal previously sensitised to the identical antigen. Synonym: reversed anaphylaxis. (05 Mar 2000) |
| pharmacologic mediators of anaphylaxis | Substances released from mast (and other) cells by the reaction of antigen and specific homocytotropic antibody on their surfaces; they include histamine, slow-reacting substance of anaphylaxis (SRS-A), bradykinin, and (in some species of animals) serotonin. (05 Mar 2000) |
| chronic anaphylaxis | A haemorrhagic and necrotizing inflammation developing in the ileum (and also the colon) of sensitised dogs when they are fed a second dose of the sensitizing material. Synonym: chronic anaphylaxis. (05 Mar 2000) |
| slow-reacting factor of anaphylaxis | Slow-reacting substance of anaphylaxis (SRS-A), a leukotriene of low molecular weight which is released in anaphylactic shock and produces slower and more prolonged contraction of muscle than does histamine; it is active in the presence of antihistamines (but not epinephrine) and seems not to occur preformed in mast cells, but as a result of an antigen-antibody reaction on the granules. Compare: peptidyl leukotrienes. Synonym: slow-reacting factor of anaphylaxis. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|